Non-Coding RNAs in Rheumatoid Arthritis: Implications for Biomarker Discovery

Area of Science:

• Molecular Biology
• Immunology
• Genetics

Background:

• Inflammatory responses, particularly in rheumatoid arthritis (RA), are complex and increasingly understood through advanced gene expression analysis.
• Genetic and epigenetic factors significantly contribute to the inflammatory state in RA.
• MicroRNAs (miRNAs) have been identified as key players in early RA pathogenesis and treatment response.

Purpose of the Study:

• To summarize current RNA-based biomarker discovery for RA.
• To discuss the impact of technology adoption, including during the COVID-19 pandemic, on biomarker research.
• To highlight the potential clinical applications of RNA biomarkers in RA.

Main Methods:

• Review of recent advances in gene expression analysis technologies (microarrays, qPCR arrays, next-generation sequencing).
• Characterization of gene expression profiles in early RA patients.
• Identification of disease-specific and treatment-response-associated miRNAs.

Main Results:

• Gene expression profiling has elucidated the complexity of inflammatory responses in RA.
• Specific miRNAs are abundant in early RA stages and correlate with treatment outcomes.
• Technological advancements have accelerated RNA-based biomarker discovery.

Conclusions:

• RNA-based biomarkers hold significant promise for preclinical RA detection and disease monitoring.
• These biomarkers can aid in identifying treatment targets and assessing treatment response.
• The integration of advanced technologies enhances the potential for clinical translation of RA biomarkers.